MLAB - Mesa Laboratories, Inc.
NASDAQ
->
Technology
->
Scientific & Technical Instruments
Lakewood,
United States
Type: Equity
MLAB price evolution
MLAB
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.47 | $28.21 | $28.22 | |
| Short term investments | ||||
| Net receivables | $40.23 | $35.57 | $39.05 | $36.02 |
| Inventory | $29.74 | $31.77 | $32.67 | $35.97 |
| Total current assets | $107.98 | $106.69 | $109.35 | $118.36 |
| Long term investments | ||||
| Property, plant & equipment | $32.07 | $31.4 | $31.77 | $31.77 |
| Goodwill & intangible assets | $289.18 | $293.85 | $578.96 | |
| Total noncurrent assets | $333.67 | $337.44 | $623.41 | |
| Total investments | ||||
| Total assets | $454.1 | $440.36 | $444.77 | $741.77 |
| Current liabilities | ||||
| Accounts payable | $5.99 | $5.66 | $6.04 | $4.55 |
| Deferred revenue | $14.63 | $15.48 | $14.36 | |
| Short long term debt | $3.75 | |||
| Total current liabilities | $153.23 | $54.87 | $44.31 | $44.18 |
| Long term debt | $104.2 | $208.5 | $221.7 | $232.97 |
| Total noncurrent liabilities | $234.77 | $257.09 | $294.63 | |
| Total debt | $212.25 | $221.7 | $232.97 | |
| Total liabilities | $292.65 | $289.63 | $299.38 | $338.81 |
| Shareholders' equity | ||||
| Retained earnings | -$178.41 | -$180.97 | -$183.49 | $71.95 |
| Other shareholder equity | -$9.67 | -$14.3 | $145.39 | -$9.84 |
| Total shareholder equity | $150.73 | $145.39 | $402.96 | |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.21 | $32.91 | $49.35 | $263.87 |
| Short term investments | ||||
| Net receivables | $39.05 | $42.55 | $41.22 | $23.79 |
| Inventory | $32.67 | $34.64 | $24.61 | $11.18 |
| Total current assets | $109.35 | $118.97 | $124.32 | $303.75 |
| Long term investments | ||||
| Property, plant & equipment | $31.77 | $28.15 | $28.62 | $22 |
| Goodwill & intangible assets | $293.85 | $503.26 | $541.28 | $272.58 |
| Total noncurrent assets | $337.44 | $542.86 | $583.05 | $297.73 |
| Total investments | ||||
| Total assets | $446.8 | $661.83 | $707.37 | $601.48 |
| Current liabilities | ||||
| Accounts payable | $6.04 | $6.13 | $7.9 | $4.47 |
| Deferred revenue | $15.48 | $14.41 | $13.83 | $8.78 |
| Short long term debt | ||||
| Total current liabilities | $44.31 | $43.36 | $48.05 | $32.58 |
| Long term debt | $221.7 | $183.27 | $218.37 | $145.68 |
| Total noncurrent liabilities | $257.09 | $224.99 | $265.51 | $162.66 |
| Total debt | $221.7 | $183.27 | $218.37 | $145.68 |
| Total liabilities | $301.4 | $268.35 | $313.57 | $195.25 |
| Shareholders' equity | ||||
| Retained earnings | -$183.49 | $74.2 | $76.67 | $72.46 |
| Other shareholder equity | -$14.76 | -$12.79 | $3.67 | $16.12 |
| Total shareholder equity | $145.39 | $393.48 | $393.8 | $406.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $57.83 | $58.17 | $58.9 | $53.47 |
| Cost of revenue | $20.92 | $20.07 | ||
| Gross Profit | $35.45 | $37.25 | $36.56 | $33.4 |
| Operating activities | ||||
| Research & development | $4.74 | $4.29 | ||
| Selling, general & administrative | $26.93 | $29.18 | ||
| Total operating expenses | $31.95 | $33.7 | $33.31 | $29.6 |
| Operating income | $3.55 | $3.8 | ||
| Income from continuing operations | ||||
| EBIT | $6.75 | $3.8 | ||
| Income tax expense | $0.38 | $0.52 | -$20.75 | -$0.17 |
| Interest expense | -$3.02 | $2.84 | $1.86 | |
| Net income | ||||
| Net income | $3.43 | $3.39 | -$254.58 | $2.12 |
| Income (for common shares) | $3.39 | $2.12 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $216.19 | $219.08 | $184.34 | $133.94 |
| Cost of revenue | $82.94 | $85.39 | $75.25 | $46.92 |
| Gross Profit | $133.25 | $133.69 | $109.09 | $87.01 |
| Operating activities | ||||
| Research & development | $19.3 | $20.49 | $15.77 | $10.39 |
| Selling, general & administrative | $111.49 | $109.88 | $88.62 | $64.18 |
| Total operating expenses | $403.2 | $130.37 | $104.39 | $74.66 |
| Operating income | -$269.95 | $3.32 | $4.7 | $12.36 |
| Income from continuing operations | ||||
| EBIT | -$269.95 | $4.38 | $7.46 | $10.33 |
| Income tax expense | -$21.4 | -$1.32 | $1.7 | -$0.97 |
| Interest expense | $5.7 | $4.77 | $3.88 | $8.02 |
| Net income | ||||
| Net income | -$254.25 | $0.93 | $1.87 | $3.27 |
| Income (for common shares) | -$254.25 | $0.93 | $1.87 | $3.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $3.39 | -$254.58 | $2.12 | |
| Operating activities | ||||
| Depreciation | $5.46 | $6.29 | $9.05 | |
| Business acquisitions & disposals | $0.96 | -$79.7 | ||
| Stock-based compensation | $2.93 | $2.79 | $2.99 | |
| Total cash flows from operations | $10.43 | $12.88 | $11.54 | |
| Investing activities | ||||
| Capital expenditures | -$0.89 | -$0.54 | -$1.13 | |
| Investments | ||||
| Total cash flows from investing | -$2.68 | -$0.89 | $0.43 | -$80.83 |
| Financing activities | ||||
| Dividends paid | -$1.73 | -$0.86 | -$0.86 | -$0.86 |
| Sale and purchase of stock | $0 | |||
| Net borrowings | -$7.22 | -$11.5 | $62 | |
| Total cash flows from financing | -$17.72 | -$9.11 | -$12.93 | $60.85 |
| Effect of exchange rate | $0.82 | -$0.17 | -$0.39 | $1.05 |
| Change in cash and equivalents | -$3.88 | $0.26 | -$0.01 | -$7.39 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$254.25 | $0.93 | $1.87 | $3.27 |
| Operating activities | ||||
| Depreciation | $31.57 | $33.82 | $25.07 | $17.66 |
| Business acquisitions & disposals | -$78.74 | -$4.95 | -$300.79 | |
| Stock-based compensation | $11.94 | $12.54 | $11.39 | $9.27 |
| Total cash flows from operations | $44.13 | $27.98 | $39.22 | $37.07 |
| Investing activities | ||||
| Capital expenditures | -$2.57 | -$4.54 | -$4.43 | -$1.99 |
| Investments | ||||
| Total cash flows from investing | -$81.31 | -$9.49 | -$305.23 | -$1.99 |
| Financing activities | ||||
| Dividends paid | -$3.45 | -$3.41 | -$3.34 | -$3.17 |
| Sale and purchase of stock | $0.36 | $7 | $7.15 | $150.36 |
| Net borrowings | $37.5 | -$36 | $49 | -$0.66 |
| Total cash flows from financing | $32.84 | -$33.33 | $52.58 | $146.23 |
| Effect of exchange rate | -$0.36 | -$1.6 | -$1.09 | $1.18 |
| Change in cash and equivalents | -$4.7 | -$16.44 | -$214.52 | $182.49 |
News
Fundamentals
| Market cap | $398.63M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 5.42M |
| Revenue | $228.38M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$245.65M |
| Revenue Q/Q | 8.78% |
| Revenue Y/Y | 6.88% |
| P/E ratio | -1.62 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.75 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$45.32 |
|---|---|
| ROA | -47.22% |
| ROE | N/A |
| Debt/Equity | 2.07 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.70 |
| Quick ratio | 0.51 |